Skip to content

Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease

Real-time fMRI Neurofeedback for Treatment of Parkinson's Disease

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01867827
Enrollment
30
Registered
2013-06-04
Start date
2013-03-31
Completion date
2014-01-31
Last updated
2017-06-21

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Parkinson's Disease

Brief summary

The aim of the study is to train patients with Parkinson's Disease to increase activity in a brain area that is involved in the control of motor functions with the use of a technique called real-time fMRI neurofeedback (NF) along with regular physical exercise. This will be a randomised and controlled clinical trial to evaluate the benefits of a novel treatment. The investigators expect NF training along with physical exercise practise to better improve motor functions compared to physical exercise alone.

Interventions

OTHERNeurofeedback and Physical Exercise
OTHERPhysical Exercise

Sponsors

Cardiff University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* People with Parkinson's Disease * Hoehn and Yahr stages 1-3 of the disease

Exclusion criteria

* Patients with dementia or significant comorbidity * those who fail the safety screening to go into an MRI scanner * those who cannot travel to the University

Design outcomes

Primary

MeasureTime frame
Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS)Change from Baseline in the 'Movement Disorder Society - Unified Parkinson's Disease Rating Scale' (MDS-UPDRS) in 12 weeks

Secondary

MeasureTime frame
Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39)Change from baseline in the 'Parkinson's Disease Questionnaire 39' (PDQ-39) at 4 weeks
Change from baseline in the 'Actigraph'Change from baseline in the 'Actigraph' at 12 weeks
Change from baseline in the 'GaitRite'Change from baseline in the 'GaitRite' at 12 weeks

Countries

United Kingdom

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026